1. Home
  2. GKOS vs UBSI Comparison

GKOS vs UBSI Comparison

Compare GKOS & UBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • UBSI
  • Stock Information
  • Founded
  • GKOS 1998
  • UBSI 1982
  • Country
  • GKOS United States
  • UBSI United States
  • Employees
  • GKOS N/A
  • UBSI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • UBSI Major Banks
  • Sector
  • GKOS Health Care
  • UBSI Finance
  • Exchange
  • GKOS Nasdaq
  • UBSI Nasdaq
  • Market Cap
  • GKOS 5.1B
  • UBSI 4.9B
  • IPO Year
  • GKOS 2015
  • UBSI N/A
  • Fundamental
  • Price
  • GKOS $89.91
  • UBSI $35.49
  • Analyst Decision
  • GKOS Strong Buy
  • UBSI Hold
  • Analyst Count
  • GKOS 13
  • UBSI 4
  • Target Price
  • GKOS $135.15
  • UBSI $40.13
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • UBSI 818.5K
  • Earning Date
  • GKOS 04-30-2025
  • UBSI 04-24-2025
  • Dividend Yield
  • GKOS N/A
  • UBSI 4.16%
  • EPS Growth
  • GKOS N/A
  • UBSI 2.88
  • EPS
  • GKOS N/A
  • UBSI 2.70
  • Revenue
  • GKOS $404,523,000.00
  • UBSI $1,039,896,000.00
  • Revenue This Year
  • GKOS $27.84
  • UBSI $17.97
  • Revenue Next Year
  • GKOS $27.88
  • UBSI $6.13
  • P/E Ratio
  • GKOS N/A
  • UBSI $13.19
  • Revenue Growth
  • GKOS 23.92
  • UBSI 2.67
  • 52 Week Low
  • GKOS $77.10
  • UBSI $30.51
  • 52 Week High
  • GKOS $163.71
  • UBSI $44.43
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • UBSI 59.82
  • Support Level
  • GKOS $84.26
  • UBSI $34.69
  • Resistance Level
  • GKOS $92.27
  • UBSI $36.00
  • Average True Range (ATR)
  • GKOS 3.94
  • UBSI 0.77
  • MACD
  • GKOS 0.57
  • UBSI 0.23
  • Stochastic Oscillator
  • GKOS 58.87
  • UBSI 82.83

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About UBSI United Bankshares Inc.

United Bankshares Inc is a financial holding company that provides banking services. The company operates in one segment: Community banking, which accepts deposits, makes loans (for personal, credit card, commercial, and construction uses), provides brokerage services, safe deposit boxes, and related services.

Share on Social Networks: